JP2022546275A - 希釈ポビドンヨード製剤を含む安定した医薬品 - Google Patents

希釈ポビドンヨード製剤を含む安定した医薬品 Download PDF

Info

Publication number
JP2022546275A
JP2022546275A JP2022510812A JP2022510812A JP2022546275A JP 2022546275 A JP2022546275 A JP 2022546275A JP 2022510812 A JP2022510812 A JP 2022510812A JP 2022510812 A JP2022510812 A JP 2022510812A JP 2022546275 A JP2022546275 A JP 2022546275A
Authority
JP
Japan
Prior art keywords
pvp
bottles
formulation
stability
pet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022510812A
Other languages
English (en)
Japanese (ja)
Other versions
JP7521721B2 (ja
Inventor
リアン，ボ
ザン，ミン
Original Assignee
アイビュー セラピューティクス，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アイビュー セラピューティクス，インコーポレイテッド filed Critical アイビュー セラピューティクス，インコーポレイテッド
Publication of JP2022546275A publication Critical patent/JP2022546275A/ja
Application granted granted Critical
Publication of JP7521721B2 publication Critical patent/JP7521721B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
JP2022510812A 2019-08-18 2020-07-08 希釈ポビドンヨード製剤を含む安定した医薬品 Active JP7521721B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962888523P 2019-08-18 2019-08-18
US62/888,523 2019-08-18
PCT/US2020/041089 WO2021034421A1 (en) 2019-08-18 2020-07-08 Stable pharmaceutical articles containing dilute povidone iodine formulations

Publications (2)

Publication Number Publication Date
JP2022546275A true JP2022546275A (ja) 2022-11-04
JP7521721B2 JP7521721B2 (ja) 2024-07-24

Family

ID=74659918

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022510812A Active JP7521721B2 (ja) 2019-08-18 2020-07-08 希釈ポビドンヨード製剤を含む安定した医薬品

Country Status (6)

Country Link
US (1) US20210401878A1 (de)
EP (1) EP4013461A4 (de)
JP (1) JP7521721B2 (de)
CN (1) CN114502205B (de)
CA (1) CA3148359A1 (de)
WO (1) WO2021034421A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3122572A1 (fr) * 2021-05-07 2022-11-11 Nadine GRISLAIN Composition pharmaceutique bioadhésive comprenant du PVPI
CN114028329A (zh) * 2021-12-24 2022-02-11 沈阳兴齐眼药股份有限公司 含有联合抑菌剂的滴眼液制剂和包含其的产品
CN114209646B (zh) * 2021-12-29 2024-01-19 艾威药业(珠海)有限公司 一种聚维酮碘温敏凝胶制剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3256997B2 (ja) * 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
NL9002049A (nl) * 1990-09-18 1992-04-16 Dagra Pharma Bv Oogheelkundig preparaat dat een povidon-joodoplossing bevat.
US5126127A (en) * 1991-07-16 1992-06-30 Euroceltique, S.A. Stabilized PVP-I solutions
JP2002000698A (ja) 2000-06-20 2002-01-08 Tomey Corp ヨード系殺菌剤含有組成物の保存方法
DK1479379T3 (da) * 2003-05-19 2008-01-02 Euro Celtique Sa Törre, liposomale PVP-iod-sammensætninger
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
EP1858482B1 (de) * 2005-03-10 2014-04-23 3M Innovative Properties Company Verfahren zur reduktion von mikrobieller kontamination
CN100536855C (zh) * 2007-11-22 2009-09-09 中国人民解放军海军医学研究所 一种聚维酮碘药物制剂及其制备方法
GB201114725D0 (en) * 2011-08-25 2011-10-12 Altacor Ltd Ophthalmic formulations
CN102429862B (zh) * 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液
CA3002384C (en) * 2015-10-25 2021-02-16 Iview Therapeutics, Inc. Pharmaceutical formulations that form gel in situ
ITUA20162425A1 (it) * 2016-04-08 2017-10-08 Medivis S R L Composizione oftalmica che comprende PVP-I
CN105853397B (zh) * 2016-04-26 2019-03-05 上海宇昂新材料科技有限公司 一种聚维酮碘浓缩液及其制备方法和应用
WO2020023666A1 (en) * 2018-07-24 2020-01-30 Orthophor, Llc Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use

Also Published As

Publication number Publication date
WO2021034421A1 (en) 2021-02-25
CN114502205B (zh) 2024-08-06
EP4013461A4 (de) 2023-08-23
US20210401878A1 (en) 2021-12-30
CA3148359A1 (en) 2021-02-25
EP4013461A1 (de) 2022-06-22
JP7521721B2 (ja) 2024-07-24
CN114502205A (zh) 2022-05-13

Similar Documents

Publication Publication Date Title
JP3531945B2 (ja) 安定なポビドン−ヨウ素眼科用溶液
JP7521721B2 (ja) 希釈ポビドンヨード製剤を含む安定した医薬品
JP7516046B2 (ja) エモリエント性の局所消毒剤
EP2747772B1 (de) Ophthalmikum
TW201808311A (zh) 安定之普維酮-碘組成物
RU2740910C2 (ru) Офтальмологическая композиция, содержащая повидон-иод
KR101305649B1 (ko) 분자 내에 불소 원자를 갖는 프로스타글란딘 함유 제품
JP7317714B2 (ja) 眼科用製品
US20200069728A1 (en) Hypochlorous acid based eye drop and ophthalmic composition
JP2016041773A (ja) ホスホニウム抗菌剤を含む薬学的組成物
WO2014120293A1 (en) Ophthalmic formulations
JP7037349B2 (ja) 水溶性粘稠化剤を含有する医薬組成物
Ali et al. Pharmaceutical development of suspension dosage form
UA139714U (uk) Назальні краплі на основі розчину колоїдного срібла
WO2024010043A1 (ja) 眼科組成物
BR112018070734B1 (pt) Composição oftálmica e preparação farmacêutica

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230413

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240226

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240524

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240604

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240626

R150 Certificate of patent or registration of utility model

Ref document number: 7521721

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150